•
Jun 30, 2017

Jazz Pharmaceuticals Q2 2017 Earnings Report

Total Revenue
$394M
Previous year: $381M
+3.5%
EPS
$2.56
Previous year: $2.63
-2.7%
Gross Profit
$366M
Previous year: $357M
+2.4%
Cash and Equivalents
$239M
Previous year: $868M
-72.4%
Total Assets
$4.8B
Previous year: $3.45B
+39.3%

Jazz Pharmaceuticals

Jazz Pharmaceuticals